![PDF) The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma PDF) The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma](https://www.researchgate.net/publication/343542653/figure/tbl2/AS:934204644798465@1599743152230/Accuracy-of-different-kl-ratio-cut-offs-for-multiple-myeloma-diagnosis_Q320.jpg)
PDF) The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/2-Table2-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/2-Table1-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
![Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table3-1.png)
Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/939f9e71-c16d-4bf8-9449-da9629dcc93a/mfig001.jpg)
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
![Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table2-1.png)
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-020-01771-3/MediaObjects/12882_2020_1771_Fig1_HTML.png)
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/2-Table1-1.png)
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png)
Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory](https://wardelab.com/wp-content/uploads/2020/06/18_2_4.jpg)
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
![PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS) PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)](https://www.researchgate.net/profile/Dirk-Larson/publication/7883288/figure/tbl2/AS:601807722127390@1520493550610/Absolute-Risk-of-Progression-of-MGUS-to-Myeloma-or-Related-Disorders-Based-on-the-Serum_Q320.jpg)
PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)
![Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-019-0210-z/MediaObjects/41408_2019_210_Fig1_HTML.png)
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
![Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-0295-4/MediaObjects/41408_2020_295_Fig1_HTML.png)
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
![PDF] Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum. | Semantic Scholar PDF] Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/062e85a70c6f2d44975de989760becdae280cc49/2-TableI-1.png)